EDITORIAL
Published on 24 Oct 2022
Editorial: Biologically active products as therapeutic options for the treatment of cardiovascular diseases related to liver injury
doi 10.3389/fphar.2022.1041020
- 582 views
- Frontiers in Pharmacology
- Ethnopharmacology
- Research Topics
- Biologically Active Products as Therapeutic Options for the Treatment of Cardiovascular Diseases Related to Liver Injury
Biologically Active Products as Therapeutic Options for the Treatment of Cardiovascular Diseases Related to Liver Injury
4,842
Total downloads
13k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 25 Jul 2022
Isochlorogenic Acid C Alleviates High-Fat Diet-Induced Hyperlipemia by Promoting Cholesterol Reverse Transport
doi 10.3389/fphar.2022.881078
- 2,506 views
- 8 citations
ORIGINAL RESEARCH
Published on 13 Jun 2022
Isolation and Quantification of the Hepatoprotective Flavonoids From Scleromitron diffusum (Willd.) R. J. Wang With Bio-Enzymatic Method Against NAFLD by UPLC–MS/MS
doi 10.3389/fphar.2022.890148
- 1,470 views
- 3 citations
ORIGINAL RESEARCH
Published on 20 May 2022
Croton urucurana Baill. Ameliorates Metabolic Associated Fatty Liver Disease in Rats
doi 10.3389/fphar.2022.886122
- 1,980 views
- 4 citations
ORIGINAL RESEARCH
Published on 05 May 2022
Geniposide Possesses the Protective Effect on Myocardial Injury by Inhibiting Oxidative Stress and Ferroptosis via Activation of the Grsf1/GPx4 Axis
doi 10.3389/fphar.2022.879870
- 3,614 views
- 39 citations
